Pancreatic Cancer Research

ResearcherNational Medical Products AdministrationActive in the last 2 years

Zhi Yang

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0003-2084-5193; OpenAlex author ID A5053846840. Sources: OpenAlex.

Their work

Papers
2 (first author 0, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
5
Papers, trials and grants by year

2024: 1 paper · 2025: 1 paper

Papers 2

  1. Construction of Bispecific T-Cell Engager Radiotracer and Its Micro-PET Evaluation in Pancreatic Cancer. Last author DOI 10.1021/acs.molpharmaceut.5c00072↗
  2. KRAS Mutation Detection with (2S,4R)-4-[18F]FGln for Noninvasive PDAC Diagnosis. Co-author DOI 10.1021/acs.molpharmaceut.4c00082↗

Closest collaborators

The 5 strongest of 5 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Hua Zhu · 2 shared papers, 2024–2025 · strength 0.46
  2. Hao Zhang · 1 shared paper, 2025 · strength 0.23
  3. Dan Wen · 1 shared paper, 2025 · strength 0.23
  4. Song Liu · 1 shared paper, 2024 · strength 0.23
  5. Xiaoxia Xu · 1 shared paper, 2024 · strength 0.23

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.